JournalofPerinatology(2017)00,1–5
©2017NatureAmerica,Inc.,partofSpringerNature.Allrightsreserved0743-8346/17
www.nature.com/jp
ORIGINAL ARTICLE
Bronchopulmonary dysplasia-associated pulmonary
hypertension: clues from placental pathology
AMKunjunju1, KRGopagondanahalli1,Y Chan2 and ASehgal1,3
OBJECTIVES:Bronchopulmonary dysplasia (BPD)and theassociated complication of pulmonary hypertension(PH) leadsto
increasedmortality anda longerlengthof stayamongsurvivors. Placental histopathology may giveearly clues ofsubsequent
events.The objective wasto evaluatetherelationship of maternalvascular underperfusion (MVU) changes on placental
histopathology with subsequentdevelopment ofBPD-associated PH inacohort ofextremely premature infants.
STUDYDESIGN:Inacohortofpreterminfants ‘⩽28weeks’gestationalage(GA)andwith‘severe’BPD,this retrospectivestudy
evaluatedspecificplacentalhistopathologicalchangesandassessedtherelationshipwithsubsequentdevelopmentofPH.‘Severe’
BPDwasdefinedastheneedfor⩾30%oxygenand/orpositivepressureventilationat36weekspostmenstrualage.Placentaland
echocardiographic assessments weredone byinvestigators masked tothegrouping and clinicaloutcomes.
RESULTS:FiftysixinfantswithsevereBPDformedthecohort;PHwasnotedin22(39.3%)infants.TheGAoftheinfantswithand
withoutPH was comparable(25.8±1.6vs25.8±1.3 weeks, P=0.9). On placentalhistopathological examination, 13(23%)had
features ofMVU.On univariate logistic regression,the presenceof changes consistent with MVUincreased therelative risk of
subsequentBPD-associatedPHby2.75(95%confidenceinterval1.56to4.85,P=0.004).Thesignificancepersistedafteradjustment
forGA. Stratificationby thepresence orabsenceof fetal growthrestriction, yielded nonsignificant associations (P=0.17).
CONCLUSION:Basedontheresultsofthepresentstudy,specificplacentalhistopathologicalchangesmaygiveearlycluestothe
subsequentdevelopment ofBPD-associated PH.
Journalof Perinatology advanceonline publication, 7September 2017; doi:10.1038/jp.2017.130
INTRODUCTION detrimentallyaffectsthefetus.9–11GivennotallcasesofMVUare
Bronchopulmonary dysplasia (BPD) is the most common chronic accompanied by clinically apparent preeclampsia or extremely
respiratorymorbidityinsurvivingpreterminfants,withareported preterm birth may occur before maternal signs are manifest, itis
incidence of ~45% in infants between 22 and 28 weeks worthinvestigatingwhetherMVUcouldserveasanindependent
gestational age (GA).1 In the NICHD Neonatal Research Network, earlier predictor of BPD and PH. The reduced vessel density and
theincidenceis~68%ininfants o29weeksGAandbirthweight abnormal vaso-reactivity of the pulmonary vasculature in infants
(BW) between 400 and 1500g.2 Recent data from Australia and withBPDprovides clues for thedevelopment ofPH.12
New Zealand Neonatal Network has noted this to be 54% in BPD is considered a multifactorial disease with involvement of
extremelypreterminfants(⩽25weeksGA).3Pulmonaryhyperten- both antenatal and postnatal risk factors.13,14 The role of chronic
sion(PH)isaknowncomplicationofBPD,theincidenceincreasing placental insufficiency as a contributor to BPD pathogenesis is a
with the severity of BPD and noted in 450% cases.4,5 This relatively understudied pathway.11 Severe chronic placental
associationalsoincreasedthemortalityininfants,whohadPHfor insufficiencyinfetalsheepresultedinpulmonaryarteryendothe-
44months.6Ourowndatahavenotedthatamonginfantsborn lial dysfunction, a recognized pathophysiology behind PH.13
⩽28weeksGAandhaving‘severe’BPD,PHcomplicated~40%of Mestanetal.15notedthatplacentalchangesofMVUmayidentify
them.7EarlyclinicalpredictorsofBPDperseincludemalegender, BPD infants with increased risk for developing PH. In a 5-year
infection,greaterventilatorrequirementsanditsassociationwith retrospective study on premature infants ⩽28 weeks GA who
patent ductus arteriosus. B-type natriuretic peptide or NT-pro-B- developed BPD (a cohort similar to our study), they showed that
type natriuretic peptide is being increasingly used for evaluation placental MVU may identify BPD infants who were exposed to
of PH in BPD.8 However, B-type natriuretic peptide could be intrauterine hypoxia ischaemia, which increases their risk for
elevatedintheabsenceofechocardiographic(ECHO)signsofPH development of PH disease subsequently. This clinically relevant
orviceversa,ismoreamarkerofventricularstrain(notspecificto information identifies a subset of infants (among a high risk
therightventricle(RV))andmaybeelevatedininfantswithpatent cohort)whomay benefit fromindividualized management.
ductus arteriosus. Placental pathologic findings related to This study evaluated the relationship of MVU changes on
maternal preeclampsia and fetal growth restriction may be early placentalhistopathologywithsubsequentdevelopmentofsevere
predictors as chronic placental malperfusion during fetal BPD-associatedPHinacohortofextremelyprematureinfants.We
development may induce pulmonary vascular remodelling, an hypothesized that in keeping with the recent literature, a
importantmarker ofPH.Maternal vascularunderperfusion (MVU) significant association between placental histopathology and
1MonashNewborn,MonashUniversityNeonatologist,MonashChildren’sHospital,Melbourne,VIC,Australia;2DepartmentofPathology,MonashHealth,Melbourne,VIC,Australia
and3DepartmentofPediatrics,MonashUniversity,Melbourne,Australia.Correspondence:ProfessorASehgal,MonashNewborn,MonashUniversityNeonatologist,Monash
Children’sHospital,246ClaytonRoad,Clayton,Melbourne,VIC3168,Australia.
E-mail:Arvind.Sehgal@monash.edu
Received6March2017;revised23June2017;accepted17July2017
PlacentalpathologyandBPD-associatedPH
AMKunjunjuetal
2
subsequent development of ‘severe’ BPD-associated PH may be
Table1. Demographicfeaturesofthestudypopulation
noticed.
Variable N=56
METHODS GA(weeks) 26±1.4
ThisretrospectivestudywasconductedatMonashChildren’sHospital,a BW(g) 796±190
quaternary centre for premature infants from 23 weeks GA onwards. Malegendern(%) 33(58)
Annually, ~175 infants with BW o1500g are admitted to the Unit. Antenatalsteroidscoveragen(%) 47(84)
Obstetric and neonatal data were collected from the Unit electronic Caesareann(%) 27(48)
database.Preterminfant’s⩽28weeksGAandhaving‘severe’BPDduring Treatmentforpatentductusarteriosus 28(50)a
the period January 2014 to May 2015 were identified from the Unit’s Sepsis 3(5.3)
electronic database. In infants born o32 weeks GA, Australia and New
Zealand Neonatal Network defines BPD as lung disease with ongoing Respiratorysupportat36weekscorrectedGA
requirement for supplemental oxygen therapy or ventilation support High-frequencyventilation 3(5)
(high-flow oxygen, continuous positive airway pressure or mechanical Nasalcontinuouspositiveairwaypressure/nasal 30(53)
ventilation)at36weekspost-menstrualage.Includedinfantsbelongedto intermittent
the ‘severe’ BPD’ category (need for ⩾30% oxygen and/or positive Mandatoryventilation
pressure ventilation at 36 weeks postmenstrual age.16 Infants with Highflow44lmin−1 17(30)
syndromic associations, surgical thoracic conditions such as congenital Lowflow 6(11)
diaphragmatic hernia and congenital heart diseases patent ductus
Abbreviations:BW,birthweight;GA,gestationalage.Figuresinparenthesis
arteriosus were excluded. Archived ECHO images were evaluated by a
representpercentages.aSubsequentsurgicalligationinone.
single investigator, masked to the placental changes or grouping. The
infantsweredividedintotwogroups;withPHandwithoutPHbasedona
prioripreviouslypublishedcriteriaonECHOdoneat36weeks’corrected
GA.7 Briefly, the parameters studied includedtricuspid regurgitation (TR)
jet maximum velocity, patent ductus arteriosus right to left shunt, Table2. Comparisonofclinicalanddemographicfactors
pulmonary artery Doppler time velocity relationship, interventricular
septum configuration, TR/velocity time integral (VTI) ratio and left Variable BPD-associatedPH NoPH(n34) P-values
ventricular systolic eccentricity index (LVsEI).17–22 Presence of any of the (n22)
above criteria indicated PH. Placental histopathology examination was
thenperformedbyahistopathologist,maskedtothegroupingorclinical GA(weeks) 25.8±1.6 25.8±1.3 0.9
outcomesoftheinfants.Althoughadescriptivehistopathologyevaluation BW(g) 776.4±226 770.2±171 0.96
of all the preterm placentas is performed at the Institution, for this APGARscoreat5mina 8(6,9) 8(6,10) 0.8
particular cohort, the histopathologist re-examined them, blinded to the Lackofantenatal 4/22(18%) 5/34(14.7%) 1
case identity. For the characterization of MVU in this cohort, the criteria steroidexposure
defined by Redline et al.23 was utilized. The study was approved by the Maternal 10(45.4%) 7(20.5%) 0.07
InstitutionalEthicsReviewCommittee. pre-eclampsia
Culture-provensepsis 1/22(4.5%) 2/34(5.8%) 1
Statistics Treatmentforpatent 10(45.4%) 18(53%) 0.78
ductusarteriosus
ContinuousvariableswerecomparedusingStudent’st-testandcategorical
variables were compared using χ2- or Fisher’s exact tests. Univariate Abbreviations: BPD, bronchopulmonary dysplasia; BW, birthweight; GA,
regressionanalysiswasusedtodeterminerelativeriskand95%confidence gestationalage;PH,pulmonaryhypertension.aMedian(range).
intervals. Regression model was adjusted for GA. All analyses were
performedusingStatasoftwareversion13.0(StataCorpLP,CollegeStation,
TX,USA).Significancewassetattwo-tailedPo0.05.
included mural fibrinoid necrosis/atherosis, muscularized basal
RESULTS plate arteries, mural hypertrophy of membrane arterioles,
Duringthestudyperiod,122infants’⩽28weeksGAatbirthwere immature intermediate trophoblast and increased placental site
admitted to the Unit. Fifty-six (44%) infants developed ‘severe’ giantcells.Inlogisticregressionanalysis,thepresenceofchanges
consistent with MVU increased the relative risk of subsequent
BPDandwereincludedinthestudycohort.Table1depictssalient
BPD-associatedPHby2.75(95%confidenceintervals1.56to4.85,
demographics. The GA of infants with and without PH was
comparable. Eleven (19%) of the cohort weighed o10th centile P=0.004). After adjustment for GA, the association still remained
and were classified as having fetal growth restriction. Table 2 significant (2.45 (95% confidence intervals 1.43, 5.01), P=0.002).
comparestheclinicalanddemographicfeaturesofthosewithand Stratification by the presence (7/11) or absence (4/11) of fetal
without PH. The incidence of maternal preeclampsia trended growthrestriction yieldednonsignificant associations (P=0.17).
higher in the BPD with PH group (P=0.07). The total duration of
respiratory support in the BPD with PH group was significantly
DISCUSSION
longercomparedwiththosewithout(224±130vs132±82days,
P=0.001).ScansfortheassessmentofPHwereperformedinthe Information from placental histopathology and biomarkers has
infantsat36.7±2weeksGA.Atleastoneparameterindicativeof recently been noted as the key to a better understanding of
PH was noted in 22 infants (multiple in 14/22); the incidence of perinataldiseasespathophysiology.Thisincludesthecommonest
BPD-associatedPHinthecohortbeing22/56(39.3%).Amongthe respiratorymorbidityaffectingprematureinfants,namelyBPD.PH
16 infants with a measurable TR jet, the ratio of TR/VTI from the as a complication of ‘severe’ BPD has gained recent recognition,
rightventricularoutflowtract(RVOT)wasnotedtobe0.28±0.03. with implications for survival, duration of stay and overall health
Table3depicts thedistributionof ECHOparameters. care resources. BPD associated PH is associated with significantly
Inthe22infantswithECHOevidenceofPH,theGAdistribution higher death rates compared with those without PH.4,5,24,25 This
was fairly even: ((23to 24 weeks; 7/15=46.6%), 25 to 26 weeks; study noted that specific placental histopathology changes may
8/24=33.3%) and 27 to 28 weeks; 7/17 (41%)). On placental hold early clues to the subsequent development of BPD-
histopathological examination masked to the grouping and associated PH in preterm infants. Our findings support the role
clinicaloutcomes,13(23%)hadfeaturesofMVU(Figure1).These of placental histopathology markers as early indicators of BPD-
JournalofPerinatology(2017), 1–5 ©2017NatureAmerica,Inc.,partofSpringerNature.
PlacentalpathologyandBPD-associatedPH
AMKunjunjuetal
3
Table3. EchocardiographicfeaturesofPH(multiplefindingsinsome)N=22
Reference Parameter Criteria Prevalence
17 TRa V ⩾2.8ms−1(~36mmHgRVSP) 13(59%)
max
18 TPV/RVETc o0.31 14(63.6%)
19 Interventricularseptumconfiguration Flatorbowedintoleftventricle 14(63.6%)
20 Patentductusarteriosus ⩾30%RighttoleftShuntincardiaccycle 0b
21 LVsEI 41.15 12(54.5%)
22 TR/VTIa 40.14 13(59%)
Abbreviations: LVsEI, left ventricular systolic eccentricity index; PH, pulmonary hypertension; RVET, right ventricular ejection time; RVSP, right ventricular
systolicpressure;TPV,timetopeakvelocity;TR,tricuspidregurgitation;VTI,velocitytimeintegral.aTotal16hadmeasurableTR.bPatentductnotedin5infants.
Figure 1. Illustration showing salient histopathological characteristics. 1 Mural fibrinoid necrosis. 2 Atherosis. 3 Muscularized basal plate
arteries.4Muralhypertrophyofmembranearterioles.5Increasedplacentalsitegiantcells.6Immatureintermediatetrophoblasts.
associated PH. Along with providing salient information to the The pulmonary vascular components of this model closely
clinician for postnatal management of these premature infants, resemble the placental histologic description of MVU in human
this adds to the growing evidence of the relevance of chronic placenta,indicatingtheroleoffetalstressorsinadverselyaffecting
placental hypoxia-ischaemia in BPD-associated PH pathogenesis. pulmonaryvasculargrowth.Inarecentlongitudinalcohortstudy
Whether the premature infant will develop BPD or not, the onpreterminfants,cordbloodmarkersassociatedwithplacental
severityofBPDandtheassociationwithPH,isnotapparentuntil MVU as predictors of BPD-associated PH have been studied.
severalweekstomonthsafterbirth.Thishasguidedthesearchfor Reduced cord blood angiogenic factors (especially placental
tangible histopathological and/or receptor level markers, which growth factors and vascular endothelial growth factor-A) were
mayprovideearlyindicationsandpotentiallybehelpfulinguiding noted as important predictors of BPD-associated PH. Decreased
themedicalmanagementprincipleswiththeultimateobjectiveof levels of these growth factors correlated with increased MVU
minimizing(or preventing)BPD. severity,indicatingtheroleofdelayedfeto-placentalangiogenesis
The pulmonary outcomes associated with MVU in extremely inthepathophysiology ofBPD-associated PH.26
preterminfantsarepoorlyunderstoodand/orunder-reported.The Interestingly, it is possible that the vascular architectural
characterization of placental lesions seems useful as it has been changes noted on placental histopathology persist during the
previously noted that chronic placental vascular mal-perfusion post-natal period. Our group has recently examined arterial
may lead to pulmonary vascular remodelling, the hallmark of structure and biomechanical function in a cohort of preterm
subsequent PH disease.15 Although Redline et al.23 previously infantswithsevereBPD,usingacohortofpreterminfantswithout
reported the association between BPD and placental changes BPDandacohortofterminfantsforcomparison.Thiscohortwas
such as fibrinoid necrosis and acute atherosis, the distinction born at ⩽28 weeks GA and was evaluated with vascular
betweenBPDwithandwithoutPHdiseasewasnotmade.Roleof ultrasoundtechniquesat36weekscorrectedGA.Thearterialwall
placental histopathology in BPD pathophysiology has been wasfoundtobesignificantlythickerandstifferandwithreduced
studied in sheep previously. In the presence of chronic fetal compliance in the infants with BPD, the significance persisting
hypoxia, it was shown that utero-placental insufficiency leads to afteradjustmentforGAandBWseparatelyaswellascombined.27
the classic histologic lung findings of BPD including pulmonary This is very similar to pulmonary arterial stiffness, which has
vascularremodelling.13Thepathologicvesselswerenotedtohave immense prognostic value in those affected by PH.28,29 A key
small lumens (low capacitance) and thick walls (high resistance). implication of these observations is that information from the
©2017NatureAmerica,Inc.,partofSpringerNature. JournalofPerinatology(2017), 1–5
PlacentalpathologyandBPD-associatedPH
AMKunjunjuetal
4
vasculature, when used as a measure of cardiovascular risk, may specific agents such as pulmonary vasodilatory and vascular
possibly identify novel therapeutic approaches, which may be growthagents needsto be studied prospectively.
useful toprevent theonset orprogression of PH.30
We assessed multiple, pre-defined and previously well studied
objective ECHO criteria. Two of them are more recent and merit CONFLICTOFINTEREST
further discussion. The lack of standardization assigned to ECHO Theauthorsdeclarenoconflictofinterest.
definitions, subjectivity of some parameters such as right heart
dilatation, the lack of universal presence of TR on ECHO and a
rotated heart affect the sensitivity and identification of PH. REFERENCES
Investigators have suggested that a TR jet maximal velocity
⩽2.8ms−1 in the absence of an additional variable would 1 Mourani PM, Mullen M, Abman SH. Pulmonary hypertension in broncho-
pulmonarydysplasia.ProgPediatrCardiol2009;27:43–48.
indicateanunlikelydiagnosisofPH.17TheratioofTRtoVTI-RVOT
2 StollBJ,HansenNI,BellEF,ShankaranS,LaptookAR,WalshMCetal.Neonatal
has been a well-studied parameter in the paediatric population.
outcomes of extremely preterm infants from the NICHD Neonatal Research
Pulmonaryvascularresistance(PVR)iscalculatedinvasivelybythe Network.Pediatrics2010;126:443–456.
ratio of trans-pulmonary pressure gradient (Δ p) to trans- 3 Chow SSW, Le Marsney R, Haslam R, Lui K. Report of the Australia and New
pulmonary flow (Qp).31 Thus, TR jet velocity and VTI-RVOT have ZealandNeonatalNetwork2014.2016.
been proposed as correlates of Δ p and Qp, respectively.32,33 As 4 AnHS,BaeEJ,KimGB,KwonBS,BeakJS,KimEKetal.Pulmonaryhypertensionin
thePVRincreases,changesinVTI-RVOTandTRjetvelocitytendto preterm infants with bronchopulmonary dysplasia. Korean Circ J 2010; 40:
occurintheoppositedirection.32,34Multiplestudieshavenoteda 131–136.
strong correlation between ECHO-derived TR/VTI-RVOT and 5 Bhat R, Salas AA, Foster C, Carlo WA, Ambalavanan N. Prospective analysis of
pulmonaryhypertensioninextremelylowbirthweightinfants.Pediatrics2012;
catheter-measured PVR. Among paediatric patients, Ajami
et al.35 noted a good correlation with catheter measured PVR
129:e682–e689.
6 FouronJC,LeGuennecJC,VillemantD,PerreaultG,DavignonA.Valueofecho-
(r2=0.53,P=0.008)withsensitivityof71.4%andspecificityof90%
cardiography inassessingthe outcome ofbronchopulmonarydysplasiaofthe
for PVR 46 Woods Units. Vlahos et al.36 also noted a similar newborn.Pediatrics1980;65:529–535.
significant correlation (r2=0.71), indicating its usefulness in 7 Revanna GK, Kunjunju A, Sehgal A. Bronchopulmonary dysplasia associated
longitudinaltrackingthesecohorts.Inaprospectiveobservational pulmonary hypertension: making the best use of bedside echocardiography.
study on children with mean age of 9.7 years, this ECHO-derived JPediatr2017;185:33–41.
ratio correlated well with catheter measured PVR (r=0.89, 8 Kim GB. Pulmonary hypertension in infants with bronchopulmonary dysplasia.
confidence intervals 0.81 to 0.94, Po0.001). For a PVR of 6 WU, KoreanJPediatr2010;53:688–693.
a TR/VTI-RVOT value of 0.14 provided a sensitivity of 96.6% and 9 BoseC,VanMarterLJ,Laughon M,O’SheaTM, Allred EN,Karna Petal.Fetal
specificityof92.8%.22Weusedthiscut-offforourstudypurpose. growthrestrictionandchroniclungdiseaseamonginfantsbornbeforethe28th
weekofgestation.Pediatrics2009;124:e450–e458.
The LVsEI is measured in two dimensions from the parasternal
10 CheckJ,GotteinerN,LiuX,SuE,PortaN,SteinhornRetal.Fetalgrowthrestriction
shortaxisviewatthemid-papillarymusclelevel.AratioofD1/D2
and pulmonary hypertension in premature infants with bronchopulmonary
iscalculatedwhereD1isthediameteroftheventricleparallelto dysplasia.JPerinatol2013;33:553e7.
the inter-ventricular septum, whereas D2 is the diameter 11 Ozkan H, Cetinkaya M, Koksal N. Increased incidence of bronchopulmonary
perpendicular to and bisecting septum. It basically measures dysplasiainpreterminfants exposedtopreeclampsia.JMaternFetalNeonatal
septal displacement. Normally, the left ventricle is circular; the Med2012;25:2681e5.
increasedRVpressureshiftstheseptumtotheleft,givingtheleft 12 Mourani PM, Abman SH. Pulmonary vascular disease in bronchopulmonary
ventricle a characteristic D-shape. A pressure-loaded RV will dysplasia: pulmonary hypertension and beyond. Curr Opin Pediatr 2013; 25:
deviate the septum in systole, reducing the denominator.37 329–337.
Normal LVsEI is 1; it increases in PH, allowing for quantification 13 RozancePJ,SeedorfGJ,BrownA,RoeG,O’MearaMC,GienJetal.Intrauterine
of a more subjective parameter of septal flattening/bowing. In growthrestrictiondecreasespulmonaryalveolarandvesselgrowthandcauses
neonates, systolic septal flattening is recognized at LVsEI⩾1.15, pulmonaryarteryendothelialcelldysfunctioninvitroinfetalsheep.AJPLungCell
MolPhysiol2011;301:L860–L871.
whereasgreaterthanhalf-systemicRVpressurebecomesapparent
14 BarkerDJ,GluckmanPD,GodfreyKM,HardingJE,OwensJA,RobinsonJS.Fetal
at LVsEI⩾1.3. Unlike qualitative assessment of septal flattening, nutritionandcardiovasculardiseaseinadultlife.Lancet1993;341:938–941.
thishas ahighinter-observer agreement.21 15 MestanKK,CheckJ,MinturnL,YallapragadaS,FarrowKN,LiuXetal.Placental
Important limitations of this study include its retrospective pathologicchangesofmaternalvascularunderperfusioninbronchopulmonary
nature and relatively small numbers. Masked review of placental dysplasiaandpulmonaryhypertension.Placenta2014;35:570–574.
slides and review by a single perinatal pathologist are among its 16 Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med
strengths. This is a single-centre study, and a multicentre study 2001;163:1723–1729.
withlargernumbersisbetterplacedtofurtheraddtothisgrowing 17 LauEM,ManesA,CelermajerDS,GalièN.Earlydetectionofpulmonaryvascular
bodyofliterature. diseaseinpulmonary arterialhypertension:timetomoveforward.EurHeartJ
We demonstrated a significant association between MVU
2011;32:2489–2498.
18 Nagiub M, Lee S, Guglani L. Echocardiographic assessment of pulmonary
placental changes and subsequent BPD-associated PH. Given the
hypertensionininfantswithbronchopulmonarydysplasia:Systematicreviewof
vascular pathophysiology seems to persist as noted on postnatal literatureandaproposedalgorithmforassessment.Echocardiography2015;32:
vascularultrasound studies, this seems an important mechanistic 819–833.
link leading to cardiopulmonary disease in early childhood. Early 19 KingME,BraunH,GoldblattA,LiberthsonR,WeymanAE.Interventricularseptal
disease predictors may aid preventive strategies in selected configurationasapredictorofrightventricularsystolichypertensioninchildren:a
populations. These may take the shape of clinical features, cross-sectionalechocardiographicstudy.Circulation1983;68:68–75.
radiological findings or laboratory-based test markers that may 20 MuseweNN,PoppeD,SmallhornJF.Dopplerechocardiographicmeasurementof
beusefulforearlydiagnosis,predictingdiseaseseverityandaidin pulmonaryarterypressurefromductalDopplervelocitiesinthenewborn.JAm
the monitoring of disease processes and/or response to therapy.
CollCardiol1990;15:446–456.
Early initiation of therapies during ‘windows of opportunity’ or a 21 Abraham S, Weismann CG. Left ventricular end-systolic eccentricity index for
assessment of pulmonary hypertension in infants. Echocardiography 2016; 33:
non-detectionofriskmayenabletheavoidance oftherapiesand
910–915.
theirpotentialhazards.38Hence,therealpotentialofthisworklies
22 Pande A, Sarkar A, Ahmed I, Naveen Chandra G, Patil SK, Kundu CK et al.
in the exciting possibility of identifying subsets of infants at
Non-invasive estimation of pulmonary vascular resistance in patients of
increasedriskofBPD-associatedPH.Whetherthisearlyidentifica-
pulmonary hypertension in congenital heart disease with unobstructed
tion will inform individualized management strategies or use of pulmonaryflow.AnnPediatrCardiol2014;7:92–97.
JournalofPerinatology(2017), 1–5 ©2017NatureAmerica,Inc.,partofSpringerNature.
PlacentalpathologyandBPD-associatedPH
AMKunjunjuetal
5
23 Redline RW, Boyd T, Campbell V, Hyde S, Kaplan C, Khong TY et al. Maternal 30 MukherjeeD.Atherogenic vascularstiffnessandhypertensioncauseoreffect?
vascular under-perfusion: nosology and reproducibility of placental reaction JAMA2012;308:919–920.
patterns.PediatrDevPathol2004;7:237–249. 31 WillardJEL,RichardA,HillisLD.Cardiaccatheterization.In:KlonerRA.TheGuideto
24 Khemani E, McElhinney DB, Rhein L, Andraade O, Lacro RV, Thomas KC et al. Cardiology,3rdedn.LeJacqCommunications:Greenwich,CT,1995,151.
Pulmonary artery hypertension in formerly premature infants with broncho- 32 Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability.
pulmonary dysplasia: clinical features and outcomes in the surfactant era. PsycholBull1979;86:420–428.
Pediatrics2007;120:1260–1269. 33 YockPG,PoppRL.Non-invasiveestimationofrightventricularsystolicpressureby
25 KimD-H,KimH-S,ChoiCW,KimE-K,KimBI,ChoiJ-H.Riskfactorsforpulmonary Dopplerultrasoundinpatientswithtricuspidregurgitation.Circulation1984;70:
artery hypertension in preterm infants with moderate or severe broncho- 657–662.
pulmonarydysplasia.Neonatology2012;101:40–46. 34 AbbasAE,FortuinFD,SchillerNB,AppletonCP,MorenoCA,LesterSJ.Asimple
26 Mestan KK, Gotteiner N, Porta N, Grobman W, Su EJ, Ernst LM. Cord blood methodfornon-invasiveestimationofpulmonaryvascularresistance.JAmColl
biomarkers of placental maternal vascular underperfusion predict broncho- Cardiol2003;41:1021–1027.
pulmonary dysplasia-associated pulmonary hypertension. J Pediatr 2017; 185: 35 AjamiGH,CherikiS,AmoozgarH,BorzoueeM,SoltaniM.AccuracyofDoppler-
33–46pii:S0022-S3476(17)30033-1. derivedestimationofpulmonaryvascularresistanceincongenitalheartdisease:
27 Sehgal A, Malikiwi A, Paul E, Tan K, Menahem S. Systemic arterial stiffness in anindexofoperability.PediatrCardiol2011;32:1168–1174.
infantswithbronchopulmonarydysplasia:potentialcauseofsystemichyperten- 36 Vlahos AP, Feinstein JA, Schiller NB, Silverman NH. Extension of Doppler-derived
sion.JPerinatol2016;36:564–569. echocardiographicmeasuresofpulmonaryvascularresistancetopatientswithmod-
28 Gan CTJ, Lankhaar JW, Westerhof N, Marcus JT, Becker A, Twisk JWR et al. erateorseverepulmonaryvasculardisease.JAmSocEchocardiogr2008;21:711–714.
Noninvasivelyassessedpulmonaryarterystiffnesspredictsmortalityinpulmon- 37 Howard LS, Grapsa J, Dawson D, Bellamy M, Chambers JB, Masani ND et al.
aryarterialhypertension.Chest2007;132:1906–1912. Echocardiographic assessment of pulmonary hypertension: standard operating
29 WangZ,CheslerN.Pulmonaryvascularwallstiffness:animportantcontributorto procedure.EurRespirRev2012;21:239–248.
theincreasedrightventricularafterloadwithpulmonaryhypertension.PulmCirc 38 Lal CV, Ambalavanan N. Biomarkers, early diagnosis, and clinical predictors of
2011;1:212–223. BPD.ClinPerinatol2015;42:739–754.
©2017NatureAmerica,Inc.,partofSpringerNature. JournalofPerinatology(2017), 1–5
